Zu den Deals
Gesundheitswesen

Shield HealthCare has sold a majority interest to Henry Schein

Shield Healthcare has sold a majority ownership position to Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners.

Founded in 1957 and headquartered in Valencia, California, Shield is one of the largest independent value-added distributors of essential medical supplies for patients and caregivers managing care in the home. The company’s diversified product catalog includes durable and consumable medical products for a wide range of patient diagnoses, including incontinence, enteral nutrition, ostomy, urology and advanced wound care. Shield operates across a nationwide footprint to provide superior solutions centered around improving patient outcomes and providing exceptional customer service and patient satisfaction.

Henry Schein is a solutions company for healthcare professionals powered by a network of people and technology. With approximately 24,000 members worldwide, the company’s network of trusted advisors provides over one million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its business, clinical, technology and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.

Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction.

Parteien

Sprechen Sie mit dem Deal-Team

Adam Abramowitz

Geschäftsführer
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Kyle Berkman

Associate Director
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

James Heskett

Associate
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Relevante Transaktionen

Cerbios-Pharma has been acquired by HAS Healthcare
Gesundheitswesen

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Weitere Informationen
Pharma-Skan & Skan-Medic have been acquired by Brygge Partners
Gesundheitswesen

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Weitere Informationen
The Canton of Solothurn had a valuation report prepared for its hospitals
Gesundheitswesen

The Canton of Solothurn had a valuation report prepared for its hospitals

The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.

Weitere Informationen